Hans Postlind

Hans Postlind has extensive work experience in the pharmaceutical and chemical industries. Hans is currently the VP of Clinical Program Planning & Execution at Sobi - Swedish Orphan Biovitrum AB, where they also held the position of VP R&D. Prior to that, they worked as a Toxicologist at the Swedish Chemicals Agency. Hans has also served as a Drug Development Consultant at HP Life Science Consulting and as a Managing Partner at RCP Pharma LLP. Additionally, they have held various roles at HP Life Science, Baxter International Inc., Karolinska Development, Nycomed, Biovitrum, and Pharmacia & Upjohn, including VP positions in non-clinical development, portfolio and project management, and preclinical development.

Hans Postlind attended Sannarps gymnasiet from 1977 to 1980. Later, they studied Pharmacy at Uppsala University from 1982 to 1986. Hans continued their education at Uppsala University from 1982 to 1990, but the degree name and field of study are unspecified.